Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 4/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28010663 | 1.00 | CYP3A4 (0.45) | CYP3A4TDP1TSHRMAPTPOLB | |
| Ammonia Solution, Strong SCHEMBL31339447 | 0.97 | CYP3A4 (0.43) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL28008458 | 0.86 | KMO (0.50) | CYP3A4ESR1PTPN1MEN1KMT2A | |
| SCHEMBL3155593 | 0.82 | CYP3A4 (0.45) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL7532752 | 0.82 | CYP3A4 (0.45) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL5034105 | 0.78 | CES2 (0.42) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL8859112 | 0.78 | CYP3A4 (0.41) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL8666770 | 0.78 | CYP3A4 (0.41) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL28702640 | 0.77 | CYP3A4 (0.45) | CYP3A4TDP1TSHRMAPTPOLB | |
| SCHEMBL18204065 | 0.76 | CES2 (0.46) | CYP3A4TDP1TSHRMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250073692-A1 | PROCESS FOR PREPARING LINEAR ALPHA-OLEFIN BY OLIGOMERIZATION OF ETHYLENE | NANJING CHEMISTRY NEW ENERGY TECHNOLOGY CO., LTD. (CN) | 2025-03-06 | — | — | US | claimed |
| US-20250073692-A1 | PROCESS FOR PREPARING LINEAR ALPHA-OLEFIN BY OLIGOMERIZATION OF ETHYLENE | NANJING CHEMISTRY NEW ENERGY TECHNOLOGY CO., LTD. (CN) | 2025-03-06 | — | — | US | disclosed |
| US-7368604-B2 | Method for the production of acylphosphine oxides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-06 | — | — | US | disclosed |
| EP-1546163-B1 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES | BASF AG (DE) | 2006-07-12 | — | — | EP | disclosed |
| US-20060052636-A1 | Method for the production of acylphosphine oxides | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| EP-1546163-A1 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004029063-A1 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-08 | — | — | WO | disclosed |
| US-5808121-A | COORDINATION CATALYSTS | BP CHEMICALS LIMITED (GB) | 1998-09-15 | — | — | US | disclosed |
| US-5525566-A | POLYMERIZATION CATALYST FOR ETHYLENE-CARBON MONOXIDE COPOLYMER | BP CHEMICALS LIMITED (GB) | 1996-06-11 | — | — | US | disclosed |
| EP-0616848-A1 | Catalyst compositions | BP Chemicals Limited (GB) | 1994-09-28 | — | — | EP | disclosed |
| US-3728366-A | LIQUID/LIQUID EXTRACTION OF COBALT VALUES | SHELL OIL CO | 1973-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052636-A1 | Method for the production of acylphosphine oxides | AGPAT5, PNPO, PHOSPHO1 | CYP3A4 588/4885TDP1 1967/4885TSHR 3990/4885 |
| US-20250073692-A1 | PROCESS FOR PREPARING LINEAR ALPHA-OLEFIN BY OLIGOMERIZATION OF ETHYLENE | EDF1, ELL, EEF1D | CYP3A4 797/4885TDP1 3485/4885TSHR 3718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.